Two Sigma Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,800
Closed -$858K 2076
2024
Q3
$858K Buy
12,800
+1,500
+13% +$123K 0.01% 959
2024
Q2
$1.28M Sell
11,300
-2,300
-17% -$291K 0.02% 949
2024
Q1
$1.89M Sell
13,600
-33,300
-71% -$4.19M 0.02% 784
2023
Q4
$5.82M Buy
46,900
+35,300
+304% +$3.61M 0.06% 329
2023
Q3
$1.08M Buy
+11,600
New +$1.31M 0.01% 987
2023
Q2
Sell
-2,000
Closed -$232K 2901
2023
Q1
$232K Buy
+2,000
New +$224K ﹤0.01% 1958
2022
Q3
Sell
-12,900
Closed -$961K 2709
2022
Q2
$961K Buy
+12,900
New +$1.18M 0.03% 547
2022
Q1
Sell
-2,000
Closed -$268K 2199
2021
Q4
$268K Sell
2,000
-6,000
-75% -$862K 0.01% 886
2021
Q3
$1.09M Buy
8,000
+800
+11% +$101K 0.03% 462
2021
Q2
$769K Buy
+7,200
New +$691K 0.02% 475
2021
Q1
Sell
-2,400
Closed -$222K 1075
2020
Q4
$222K Buy
+2,400
New +$214K 0.01% 1306

Other funds holding DXCM

Two Sigma Securities's DXCM Position: Q1 2026 in Review

Two Sigma Securities opened a new position in DexCom (DXCM) in Q1 2026: 3,251 shares worth $204K. The stake represents 0.02% of the portfolio and ranks #1047 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in DXCM as recently as Q1 2025.

Two Sigma Securities first reported a position in DXCM in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.63M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Two Sigma Securities held 3,251 shares of DexCom worth $204K as of Q1 2026.
  • DexCom was a new Two Sigma Securities position in Q1 2026.
  • DexCom made up 0.02% of Two Sigma Securities's portfolio in Q1 2026, its #1047 holding.
  • Two Sigma Securities first reported a position in DexCom in Q3 2020 and has held it in 8 quarters since.
  • Two Sigma Securities's DexCom position peaked at $1.63M in Q2 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.